-+ 0.00%
-+ 0.00%
-+ 0.00%

Q32 BIO ANNOUNCES UPCOMING LATE-BREAKING PRESENTATION OF RESULTS FROM PART B OF THE SIGNAL-AA CLINICAL TRIAL OF BEMPIKIBART IN ALOPECIA AREATA AT THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY CONGRESS 2026

Reuters·09/21/2026 13:17:09